Phosphoproteomics of MAPK inhibition in BRAF-mutated cells and a role for the lethal synergism of dual BRAF and CK2 inhibition.
about
Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.Phosphoproteomic Analysis of Cell-Based Resistance to BRAF Inhibitor Therapy in Melanoma.Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerA Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma Cells.CK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.A compendium of ERK targets.Protein kinase CK2 in breast cancer: the CK2β regulatory subunit takes center stage in epithelial plasticity.The kinome 'at large' in cancer.Phosphoproteomics Reveals MAPK Inhibitors Enhance MET- and EGFR-Driven AKT Signaling in KRAS-Mutant Lung Cancer.Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant MelanomaSpecific inhibition of CK2α from an anchor outside the active siteImpact of phosphoproteomics in the translation of kinase-targeted therapies.Novel targeted therapies and immunotherapy for advanced thyroid cancers.
P2860
Q30363869-1E90E5F9-9A70-44F5-BA0E-D86AE1D4C783Q35609071-F73FDCCC-66A6-4D28-909B-AC3B01E0C83EQ35657842-1760E0B3-37F9-4E93-8619-33A1729DCA2BQ35692123-7791914C-F061-493D-9425-E95B12551BCAQ36263671-A1681A59-8EA9-4F53-975F-0662E3002322Q38373402-401578EC-C032-4731-8C51-6A11963C3C7DQ38492153-28FC2FA1-A7D7-40CB-8704-0FDE72A73D10Q38715428-60259748-B20D-4053-9341-0B8CA1070921Q38757884-DEDDE37B-109B-443F-89A7-C96C836EBB54Q38768362-29D9AFB1-680E-486E-BAFD-090F41F19569Q38815725-C258C332-2866-456A-87C7-38C691F6B3CFQ38989188-F4F58D26-1CD1-420F-89CC-46D79417A0FEQ49887965-ADA385E5-3673-4F26-97CC-7302BC0356FE
P2860
Phosphoproteomics of MAPK inhibition in BRAF-mutated cells and a role for the lethal synergism of dual BRAF and CK2 inhibition.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Phosphoproteomics of MAPK inhi ...... dual BRAF and CK2 inhibition.
@en
type
label
Phosphoproteomics of MAPK inhi ...... dual BRAF and CK2 inhibition.
@en
prefLabel
Phosphoproteomics of MAPK inhi ...... dual BRAF and CK2 inhibition.
@en
P2093
P50
P1476
Phosphoproteomics of MAPK inhi ...... f dual BRAF and CK2 inhibition
@en
P2093
Mark P Molloy
Robert Parker
Roderick Clifton-Bligh
P304
P356
10.1158/1535-7163.MCT-13-0938
P577
2014-05-13T00:00:00Z